William B. White, MD
NPI 1760489546ActiveIndividual· Internal Medicine, Hypertension Specialist· Farmington, CT
Internal Medicine, Hypertension Specialist (MD) in Farmington, Connecticut, licensed in CT, with an NPI issued in July 2005. Sumitomo Pharma America, Inc. was the largest of 9 companies reporting payments in 2025, $398,625 in all, mostly consulting fees.
Overview
| NPI | 1760489546 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jul 7, 2005 |
| Last updated in NPPES | Jun 15, 2012 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Hypertension Specialist Primary | 207RH0005X | 021723 | CT |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 4, 2026 | No match | — |
| New York OMIG · Nov 4, 2026 | No match | — |
| Ohio Medicaid · Nov 4, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 4, 2026 | No match | — |
| Washington HCA · Nov 4, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Industry payments (Open Payments)
- 2025$398,625 · 58 payments from 9 companies
- 2024$357,302 · 63 payments from 10 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Sumitomo Pharma America, Inc. | $222,530 | 15 |
| Astrazeneca Pharmaceuticals LP | $40,868 | 10 |
| Alnylam Pharmaceuticals Inc. | $40,837 | 9 |
| Takeda Pharmaceuticals U.S.A., Inc. | $34,856 | 6 |
| Astrazeneca Uk Limited | $23,394 | 9 |
What the 2025 payments were for
- Consulting Fee$398,625 · 58 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Hypertension Specialist providers in Farmington
- 1023015898
All Internal Medicine, Hypertension Specialist providers in Connecticut →